The CDC Prevention Grant Funding Opportunity

Announcement (FOA) and OA’s Response

Overview and DiscussionSeptember 21, 2011

California Department of Public Health, Office of AIDS

Introduction & BackgroundStructure for OA-funded activities:

Tier I and Tier II

Changes to HIV Prevention ProgramsAllocationsNext StepsDiscussion and Q&A

Agenda

New Direction in HIV Prevention

Identify people with HIV infectionLink to care, retain and reengage Reduce viral load for individuals and the

community

The CDC FOA

A more prescriptive approach which emphasizes:HIV testingPrevention with positives and their partners Services in medical settings Structural and policy interventions Increasing collaboration between prevention and care

Overview of OA’s Response

OA’s Design for Prevention Activities: Tier I and Tier II• OA’s Tier I and Tier II activities reflect the priorities

described in the FOA• OA will take on some of these activities• LHJs will be able to choose among Tier I activities (or

implement all)• LHJs may choose to implement Tier II activities when

Tier I activities have all been met

Tier I Activities

• Testing • Linkage to care• Partner services• Risk assessment, linkages

to services and behavioral interventions for HIV+ people

• HIV treatment adherence• Syringe services programs

• Policy initiatives– Surveillance data use – Leveraging SAMHSA HIV set-

aside funds– Healthcare reform planning

• Condom distribution & syringe supply bank

• State community planning

Tier II - Activities

• Hepatitis C testing (can test in non-healthcare settings prior to fulfilling all Tier I activities)

• Integrated HIV, hepatitis, TB and STD screening

• Behavioral interventions for high-risk negative people

• Social marketing, media and mobilization

• Pre-exposure prophylaxis (PrEP) planning and/or delivery

• All Tier I activities must be implemented before funding can be used for Tier II activities.

• Tier I activities may be funded with either OA funding or other funding.

• The Expanded Testing in Healthcare Settings funding, which had been a separate grant from the CDC, has been integrated into this CDC prevention grant as Category B.

Details of the Tier Design

HIV Test kits to funded CPA jurisdictionsCA AIDS Clearinghouse supplies to all CPG LHJs:

Condoms Harm reduction materials and syringe supply bankEducational materials

LEO is available for use by all LHJs

OA Resources

• Settings - more emphasis on healthcare settings for HIV positive people, and linkages

• Targets - more emphasis on HIV positive individuals and their partners

• Activities – even more emphasis on evidence-based interventions

CDC Changes for Prevention Programs

Process for Program Implementation

• Fiscal implementation: January 1, 2012• Programmatic implementation: July 1, 2012• This provides a 6-month period to adjust

prevention programs to new directions

Fiscal Implementation

• Application of allocation formula cannot be done until official award amount is provided.– CDC did not include a date awards will be announced.

• There will be more funds available for allocation to the funded LHJs. Models of possible award amounts have been developed. A draft was provided to CCLAD members.

• A supplemental grant award will be provided for January 1, 2012 through June 30, 2012.

• New award amounts will be used for FY 12-13.

Allocation Funding Formula

Previous formula• New HIV infections identified

through C&T (3 years) (20%)• % Newly reported HIV cases

(20%)• % Living AIDS cases (20%)• % Male syphilis (1 year) (7.5%)• % Male gonorrhea (1 year)

(7.5%)• % Non-Hispanic AA (15%)• % Hispanics (5%)• % Below poverty level (5%)

Current formula• % People living with HIV and

AIDS, excluding state prison cases (75%)

• % Non-Hispanic AA (15%)• % Hispanics (5%)• % Below poverty level (5%)

• Activities between January 1st and July 1st may include:

• Maintaining some activities• Concluding some activities• Planning for some new activities

• OA has been granted transitional funding• Transitional funding will assist programs

requiring significant alteration as a result of the new grant direction.

Transition Period

Timeline: Program-Specific Webinars

October 13th – Transitional Period

October 20th – Testing Activities

October 27th – PWP Activities

November 3rd – Policy Initiatives

November 10th – Syringe Service Programs & California AIDS Clearinghouse

November 17th – Tier II Activities (Social Marketing, HE/RR for High Risk Negatives, Hep C Testing, PrEP)

December 8th – Putting it All Together

To provide feedback on OA’s response to the FOA, please send comments to:

OAFeedback@cdph.ca.gov